alogliptin
Showing 1 - 25 of 39
Diabetes, Type 2 Trial in Guangzhou (SAL067, Alogliptin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- SAL067
- +2 more
-
Guangzhou, Guangdong, China1. Sun Yat-sen Memorial Hospital, Sun Yat-sen University,
Mar 21, 2023
Type 2 Diabetes Trial in China (Alogliptin, Acarbose, Metformin)
Completed
- Type 2 Diabetes Mellitus
- Alogliptin
- +3 more
-
China, ChinaCHINA
Apr 18, 2022
Diabetes, Type 2 Trial in Korea, Republic of (Pioglitazone + Alogliptin, Alogliptin, Metformin)
Recruiting
- Diabetes Mellitus, Type 2
- Pioglitazone + Alogliptin
- +3 more
-
Bucheon-si, Gyeonggi-do, Korea, Republic of
- +14 more
Apr 7, 2022
"Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With
Completed
- Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution
- Alogliptin
-
Osaka, Japan(unnamed)
Nov 6, 2019
Healthy Volunteers Trial in Yaroslavl (Alogliptin, Pioglitazone, SYR-322-4833 BL)
Completed
- Healthy Volunteers
- Alogliptin
- +2 more
-
Yaroslavl, Russian FederationNon-governmental healthcare Institution Road Clinical Hospital a
Jun 24, 2019
Alogliptin and Alogliptin Fixed-Dose Combinations With
Terminated
- Diabetes Mellitus, Type 2
- Alogliptin
- +2 more
-
Beijing, Beijing, China
- +10 more
Jan 23, 2019
Diabetes, Type 2 Trial in Seoul (alogliptin+pioglitazone, alogliptin, pioglitazone)
Terminated
- Diabetes Mellitus, Type 2
- alogliptin+pioglitazone
- +2 more
-
Seoul, Korea, Republic ofSeoul St Mary's Hospital, The Catholic University of Korea
Jun 3, 2019
Type 2 Diabetes Trial in Seoul (alogliptin, Pioglitazone, alogliptin + pioglitazone)
Completed
- Type 2 Diabetes Mellitus
- alogliptin
- +2 more
-
Seoul, Korea, Republic ofSeoul St Mary's Hospital, The Catholic University of Korea
Feb 7, 2019
Type 2 Diabetes Trial in Naka-city (Trelagliptin, Alogliptin)
Completed
- Type 2 Diabetes Mellitus
- Trelagliptin
- Alogliptin
-
Naka-city, Ibaragi, Japan(unnamed)
Dec 11, 2018
Type 2 Diabetes Trial in Suita, Shinjuku (Trelagliptin, Alogliptin)
Diabetes, Type 2 Trial (Alogliptin)
Withdrawn
- Diabetes Mellitus, Type 2
- Alogliptin
- (no location specified)
Oct 18, 2017
Type 2 Diabetes Trial in Chula Vista, Orlando (Roflumilast, Alogliptin, Exenatide)
Diabetes Trial in Worldwide (Alogliptin, Metformin HCl, Alogliptin and Metformin Fixed-Dose Combination (FDC))
Completed
- Diabetes Mellitus
- Alogliptin
- +5 more
-
Beijing, Beijing, China
- +44 more
Oct 4, 2016
Healthy Volunteers Trial (Alogliptin, Metformin Hydrochloride, SYR-322MET)
Completed
- Healthy Volunteers
- Alogliptin
- +2 more
- (no location specified)
Oct 4, 2016
Type 2 Diabetes Trial in Japan (Alogliptin, Metformin HCl, Metformin HCl Placebo)
Completed
- Type 2 Diabetes Mellitus
- Alogliptin
- +2 more
-
Nagoya-shi, Aichi, Japan
- +26 more
Apr 28, 2016
Diabetes Trial in Japan (Alogliptin, Rapid-acting insulin secretagogue)
Completed
- Diabetes Mellitus
- Alogliptin
- Rapid-acting insulin secretagogue
-
Nagoya-shi, Aichi, Japan
- +13 more
Mar 17, 2014
Diabetes, Type 2, Acute Coronary Syndrome Trial in Worldwide (Alogliptin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Acute Coronary Syndrome
- Alogliptin
- Placebo
-
Birmingham, Alabama
- +917 more
Apr 15, 2014
Diabetes Trial in Amsterdam, Gothenburg (Alogliptin and Pioglitazone, Alogliptin, Placebo)
Completed
- Diabetes Mellitus
- Alogliptin and Pioglitazone
- +2 more
-
Amsterdam, Netherlands
- +1 more
May 23, 2013
Type 2 Diabetes Trial in Worldwide (Alogliptin, Metformin, Glipizide)
Completed
- Type 2 Diabetes Mellitus
- Alogliptin
- +2 more
-
Montgomery, Alabama
- +261 more
Sep 25, 2013
Pharmacokinetics and Pharmacodynamics Trial in Seoul (Alogliptin)
Completed
- Pharmacokinetics and Pharmacodynamics
- Alogliptin
-
Seoul, Korea, Republic of(unnamed)
Feb 17, 2013